Monthly Archives - March 2021

Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) developing new classes of synthetic anti-infectives

31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.

Read more...

Flights cancelled to Brisbane after Covid uncertainty: ASX poised to open higher

31 Mar 2021 - Following mixed leads from US markets, the ASX looks set to open lower. US stocks fell yesterday as major tech shares came under pressure again after the 10-year Treasury yield touched its highest level since January 2020. Shares in Apple, Microsoft and Amazon all fell. At least 75 flights have been cancelled to Brisbane during the first day of lockdown after a breakout of coronavirus. Suncorp (ASX:SUN) assesses the claims from the recent rain event...

Read more...

The telcos sector led the gains today: ASX closed 0.9% lower

30 Mar 2021 - Mid morning trade saw a drop for the Australian share market and it failed to recover. At the closing bell the S&P/ASX 200 index closed 61points lower, or 0.9 per cent lower to finish at 6,738. Santos (ASX:STO), as operator of the Barossa joint venture, today announced a final investment decision (FID) has been taken to proceed with the US$3.6 billion gas and condensate project.

Read more...